Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct‐Acting Antivirals

It is unclear whether eradication of hepatitis C virus (HCV) leads to a reduction in the risk of hematologic malignancies. We aimed to determine the impact of sustained virologic response (SVR) induced by either direct‐acting antivirals (DAAs) or interferon (IFN) on the risk of hematologic malignanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ioannou, George N., Green, Pamela K., Berry, Kristin, Graf, Solomon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671776/
https://www.ncbi.nlm.nih.gov/pubmed/31388632
http://dx.doi.org/10.1002/hep4.1389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6671776/
https://www.ncbi.nlm.nih.gov/pubmed/31388632
http://dx.doi.org/10.1002/hep4.1389

Ejemplares similares